Montesi, S. B., Gomez, C. R., Beers, M., Brown, R., Chattopadhyay, I., Flaherty, K. R., Garcia, C. K., Gomperts, B., Hariri, L. P., Hogaboam, C. M., Jenkins, R. G., Kaminski, N., Kim, G. H. J., Königshoff, M., Kolb, M., Kotton, D. N., Kropski, J. A., Lasky, J., Magin, C. M., … Martinez, F. J. (2024). Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report. American Journal of Respiratory and Critical Care Medicine, 209(4), 362–373. https://doi.org/10.1164/rccm.202307-1154ws

Snyder, M. E., Anderson, M. R., Benvenuto, L. J., Sutton, R. M., Bondonese, A., Koshy, R., Burke, R., Clifford, S., Craig, A., Iasella, C. J., Hannan, S. J., Popescu, I., Zhang, Y., Sanchez, P. G., Alder, J. K., & McDyer, J. F. (2023). Impact of age and telomere length on circulating T cells and rejection risk after lung transplantation for idiopathic pulmonary fibrosis. The Journal of Heart and Lung Transplantation, 42(12), 1666–1677. https://doi.org/10.1016/j.healun.2023.08.001

Kim, J. S., Montesi, S. B., Adegunsoye, A., Humphries, S. M., Salisbury, M. L., Hariri, L. P., Kropski, J. A., Richeldi, L., Wells, A. U., Walsh, S., Jenkins, R. G., Rosas, I., Noth, I., Hunninghake, G. M., Martinez, F. J., & Podolanczuk, A. J. (2023). Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Annals of the American Thoracic Society, 20(12), 1683–1693. https://doi.org/10.1513/annalsats.202303-188ps

Zhang, D., Adegunsoye, A., Oldham, J. M., Kozlitina, J., Garcia, N., Poonawalla, M., Strykowski, R., Linderholm, A. L., Ley, B., Ma, S.-F., Noth, I., Strek, M. E., Wolters, P. J., Garcia, C. K., & Newton, C. A. (2023). Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. European Respiratory Journal, 62(5), 2300441. https://doi.org/10.1183/13993003.00441-2023

Kim, J. S., Murray, S., Yow, E., Anstrom, K. J., Kim, H. J., Flaherty, K. R., Martinez, F. J., & Noth, I. (2024). Comparison of Pirfenidone and Nintedanib. CHEST, 165(5), 1163–1173. https://doi.org/10.1016/j.chest.2023.11.035

Kim, J. S., Ma, S.-F., Ma, J. Z., Huang, Y., Bonham, C. A., Oldham, J. M., Adegunsoye, A., Strek, M. E., Flaherty, K. R., Strickland, E., Udofia, I., Mooney, J. J., Ghosh, S., Maddipati, K., & Noth, I. (2024). Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis. CHEST, 165(3), 621–631. https://doi.org/10.1016/j.chest.2023.09.035

Moll, M., Peljto, A. L., Kim, J. S., Xu, H., Debban, C. L., Chen, X., Menon, A., Putman, R. K., Ghosh, A. J., Saferali, A., Nishino, M., Hatabu, H., Hobbs, B. D., Hecker, J., McDermott, G., Sparks, J. A., Wain, L. V., Allen, R. J., Tobin, M. D., … Cho, M. H. (2023). A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities. American Journal of Respiratory and Critical Care Medicine, 208(7), 791–801. https://doi.org/10.1164/rccm.202212-2257oc

Capaccione, K. M., & Salvatore, M. M. (2023). Radiographic grading system for usual interstitial pneumonia correlates with mortality and may serve as a surrogate endpoint in clinical trials. Clinical Imaging, 102, 37–41. https://doi.org/10.1016/j.clinimag.2023.07.002

McGroder, C. F., Zhang, D., Choudhury, M., Podolanczuk, A. J., Lederer, D., Hoffman, E. A., Saqi, A., Capaccione, K. M., D’Souza, B., Salvatore, M. M., & Garcia, C. K. (2023). Radiographic Lung Abnormalities in First-Degree Relatives of Patients With Different Subtypes of Pulmonary Fibrosis. CHEST, 163(6), 1471–1475. https://doi.org/10.1016/j.chest.2023.01.012

Peljto, A. L., Blumhagen, R. Z., Walts, A. D., Cardwell, J., Powers, J., Corte, T. J., Dickinson, J. L., Glaspole, I., Moodley, Y. P., Vasakova, M. K., Bendstrup, E., Davidsen, J. R., Borie, R., Crestani, B., Dieude, P., Bonella, F., Costabel, U., Gudmundsson, G., Donnelly, S. C., … Schwartz, D. A. (2023). Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. American Journal of Respiratory and Critical Care Medicine, 207(9), 1194–1202. https://doi.org/10.1164/rccm.202207-1331oc

Hosseini, M., & Salvatore, M. (2023). Is pulmonary fibrosis a precancerous disease? European Journal of Radiology, 160, 110723. https://doi.org/10.1016/j.ejrad.2023.110723

Shou, A. Y., & Salvatore, M. M. (2023). CT predictors of outcomes in patients with connective tissue disease and progressive lung fibrosis. Clinical Imaging, 94, 42–49. https://doi.org/10.1016/j.clinimag.2022.11.022

Pugashetti, J. V., Adegunsoye, A., Wu, Z., Lee, C. T., Srikrishnan, A., Ghodrati, S., Vo, V., Renzoni, E. A., Wells, A. U., Garcia, C. K., Chua, F., Newton, C. A., Molyneaux, P. L., & Oldham, J. M. (2023). Validation of Proposed Criteria for Progressive Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 207(1), 69–76. https://doi.org/10.1164/rccm.202201-0124oc

Dobrinskikh, E., Hennessy, C. E., Kurche, J. S., Kim, E., Estrella, A. M., Cardwell, J., Yang, I. V., & Schwartz, D. A. (2023). Epithelial Endoplasmic Reticulum Stress Enhances the Risk of Muc5b-associated Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology, 68(1), 62–74. https://doi.org/10.1165/rcmb.2022-0252oc

Zhang, D., Newton, C. A., Wang, B., Povysil, G., Noth, I., Martinez, F. J., Raghu, G., Goldstein, D., & Garcia, C. K. (2022). Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis. European Respiratory Journal, 60(6), 2200577. https://doi.org/10.1183/13993003.00577-2022

Lee, J., White, E., Freiheit, E., Scholand, M. B., Strek, M. E., Podolanczuk, A. J., Patel, N. M., Bascom, R., Belloli, E., Bhatt, N., Bhorade, S., Case, A., Castriotta, R., Criner, G., Danoff, S., De Andrade, J., Desai, A., Glassberg, M., Glazer, C., … Wolters, P. (2022). Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease. CHEST, 162(3), 603–613. https://doi.org/10.1016/j.chest.2022.03.025

Newton, C. A., Oldham, J. M., Applegate, C., Carmichael, N., Powell, K., Dilling, D., Schmidt, S. L., Scholand, M. B., Armanios, M., Garcia, C. K., Kropski, J. A., & Talbert, J. (2022). The Role of Genetic Testing in Pulmonary Fibrosis. CHEST, 162(2), 394–405. https://doi.org/10.1016/j.chest.2022.03.023

Zhang, D., Povysil, G., Kobeissy, P. H., Li, Q., Wang, B., Amelotte, M., Jaouadi, H., Newton, C. A., Maher, T. M., Molyneaux, P. L., Noth, I., Martinez, F. J., Raghu, G., Todd, J. L., Palmer, S. M., Haefliger, C., Platt, A., Petrovski, S., Garcia, J. A., … Garcia, C. K. (2022). Rare and Common Variants in KIF15 Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 206(1), 56–69. https://doi.org/10.1164/rccm.202110-2439oc

Bowman, W. S., Newton, C. A., Linderholm, A. L., Neely, M. L., Pugashetti, J. V., Kaul, B., Vo, V., Echt, G. A., Leon, W., Shah, R. J., Huang, Y., Garcia, C. K., Wolters, P. J., & Oldham, J. M. (2022). Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis. The Lancet Respiratory Medicine, 10(6), 593–602. https://doi.org/10.1016/s2213-2600(21)00503-8

Popmihajlov, Z., Sutherland, D. J., Horan, G. S., Ghosh, A., Lynch, D. A., Noble, P. W., Richeldi, L., Reiss, T. F., & Greenberg, S. (2022). CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial. BMJ Open Respiratory Research, 9(1), e001060. https://doi.org/10.1136/bmjresp-2021-001060